Grüneberg and Myers Firm and Partners repeat listing in IAM Patent 1000

Intellectual Asset Management (IAM) magazine released the 2025 edition of its annual guide to the world’s top patent practitioners, recommending the Grüneberg and Myers firm as a whole, and both co-founding partners individually, for patent prosecution.

In the highly competitive Washington, DC area, Grüneberg and Myers received a place in the IAM Patent 1000 DC-area listings. Fewer than 40 other firms made the patent prosecution list, which also includes several multicity and multinational AmLaw 100 firms.

Noting the firm’s work for numerous large global companies, IAM cites rave reviews, highlighting the following:

“The Grüneberg and Myers team provides an excellent, client-focused service and an unrivalled cost benefit ratio. It is one of the best firms for patent prosecution in the US and the scope of granted patents is well beyond what could be reasonably expected.” Dr. Grüneberg enjoys a prominent national reputation for her patent prowess, earning the trust of the globe’s largest chemical, biotech and pharmaceutical companies. Also highly rated is Dr. Richard Chinn, another organic chemistry PhD who excels in handling matters related to chemical technology.

A resource for identifying world-class patent attorneys in private practice, the IAM Patent 1000 bases its list not just on buzz, but on interviews with clients and other practicing patent attorneys. The quantitatively-evaluated listings account for depth of knowledge, market presence, level of work, and positive peer and client feedback.

For more information, please see the Grüneberg and Myers firm profile on the IAM Patent 1000 website, along with the IAM Patent 1000 profiles for Dr. Grüneberg, and Dr. Chinn.

Launched in September 2017, Grüneberg and Myers PLLC is a 100 percent female- and ethnic minority-owned international patent firm. With a broad and sophisticated practice, the firm provides a full range of patent support services, including patent prosecution, counseling, post-grant representation, and M&A due diligence to meet the growing and diverse needs of U.S.-based, European, and Asian companies, entrepreneurs, and inventors.